Bristol and Merck Shares Surge on Cancer Drug News
June 03, 2013 at 15:32 PM EDT
Developmental drugs from Bristol-Myers Squibb and Merck wowed a major oncology meeting and drove both companies' shares higher Monday as analysts said billions stood to be made from treatment breakthroughs.
